Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extra energy for hearts with a genetic defect: ENERGY trial
2018-000029-29Phase 2Completed
- Sponsor
- VU University Medical Center
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of trimetazidine in hypertrophic cardiomyopathy (HCM), sponsored by VU University Medical Center. Primary endpoints: Myocardial efficiency assessed by 11C-acetate PET/CT and cardiac MRI and Diastolic cardiac function. Started Dec 2018; status: completed.
02
Drugs
trimetazidine
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on 2018-000029-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000029-29.